site stats

Statin decision aid for patients

Webhas the potential to improve patient outcomes. Decision aids are an effective way for both patients and caregivers to conduct joint decision-making at the point of treatment (Ye et al., 2024). Statin Choice Decision Aid The SCDA is designed to determine the patient’s 10-year ASCVD risk score and WebNov 10, 2024 · Statin use among patients with atherosclerotic cardiovascular disease remains suboptimal because of various patient‐ and clinician‐related factors. The development of a decision aid to facilitate discussion of SASEs, clinician decision‐making, and SASE management may improve statin use in this high‐risk population.

Are statins the best choice for me? - National Institute for …

WebSetting and participants: Twenty-two patients with diabetes (57% of them on statins) and six endocrinologists working in a referral diabetes clinic randomly assigned to use the decision aid during the consultation. Main outcome measures: Proportion and nature of unintended use of the Statin Choice decision aid. WebThis decision aid is intended to help patients in whom treatment with a statin is being considered, for primary or secondary prevention of cardiovascular disease (CVD). Primary prevention means they have never had a stroke or heart attack and Secondary Prevention means they have. Whether you decide to take a statin or not we always advice birth control generic brand https://simobike.com

Taking a statin to reduce the risk of coronary ... - NICE

WebAbstract. Objective: To assess the impact of a decision aid on perceived risk of heart attacks and medication adherence among urban primary care patients with diabetes. Methods: We randomly allocated 150 patients with diabetes to participate in a usual primary care visit either with or without the Statin Choice tool. WebThe Statin Choice 1-page decision aid included the patient's name, cardiovascular risk factors, and 1 of 3 levels of baseline 10-year cardiovascular risk: 10% for patients with 10-year cardiovascular risk less than 15%, 7 20% for patients with estimated risk between 15% and 30%, and 50% for patients with estimated risk greater than 30%. WebStatins should be used with caution in patients at increased risk of muscle toxicity, such as the elderly, those with a personal or family history of muscular disorders, history of muscular toxicity or unexplained persistent muscle pain, history of liver disease, a high alcohol intake, known genetic polymorphisms—consult product literature, renal … birth control guide fda

Statin Choice Decision AID - Site - Mayo Clinic

Category:Shared Decisions: A Qualitative Study on Clinician and Patient ...

Tags:Statin decision aid for patients

Statin decision aid for patients

Using Statin Choice Decision-Aid Tool and Laboratory Testing ... - Insights

WebA total of seven clinicians were enrolled and underwent a 12-hour, group-based, in-person training on shared decision making (SDM) and the Statin Choice decision aid. Then, these clinicians used the Statin Choice decision aid in patients during a clinical encounter. A total of 86 patients aged 40-80 years, who had stable angina, were enrolled. WebJan 25, 2024 · With more than 70,000 uses worldwide and policy endorsements for its use (JAMA article), the Mayo Clinic Statin Choice Decision-Aid tool is helping patients and their clinicians have meaningful conversations about whether or not to use statins to reduce cardiovascular (CV) risk.This tool was developed by the Mayo Clinic Knowledge and …

Statin decision aid for patients

Did you know?

WebOct 11, 2024 · Purpose of review: Our aim was to examine the current evidence behind prescribing statins to individuals over 65 years of age with emphasis on those older than 75. Individuals over 75 years of age may often have multiple … WebStatins include atorvastatin (Lipitor), fluvastatin (Lescol XL), lovastatin (Altoprev), pitavastatin (Livalo), pravastatin (Pravachol), rosuvastatin (Crestor, Ezallor) and simvastatin (Zocor, FloLipid). Having too much cholesterol in your blood increases your risk of heart attacks and strokes.

WebStatin Choice Decision AID - Site Current Risk Select Risk Calculator ACC/AHA ASCVD Framingham Reynolds Do you have a history of events such as prior heart attack or stroke, acute coronary syndromes, history of angioplasty or stents, etc? These figures are used to calculate my risk of having a heart attack in the next 10 years: Age Gender WebThis decision aid is intended to help you to make up your mind whether or not to take a statin to help reduce your risk of having a heart attack or developing angina (together called coronary heart disease or CHD), or of having a stroke.

WebThis tool is a statistical model and is not a substitute for an individual treatment plan developed by a health care provider with personal knowledge of a specific patient. Factors such as medical history and the health care provider’s experience, knowledge, and training must also be considered. WebMar 18, 2024 · Statins: Are these cholesterol-lowering drugs right for you? Atorvastatin (Lipitor) Fluvastatin (Lescol XL) Lovastatin (Altoprev) Pitavastatin (Livalo, Zypitamag) Pravastatin (Pravachol) Rosuvastatin (Crestor, Ezallor) Simvastatin (Zocor)

WebNov 11, 2024 · This decision aid should summarize recent guidelines on statin use, and include statin starting dosages, options for various statins, safety profiles, strategies to manage SASEs (eg, nonstatin alternatives, ruling out secondary causes of SASEs, and statin titration), and strategies to rechallenge statin intolerant patients. Clinicians felt the ...

WebJun 11, 2024 · Statins are a group of medicines that are commonly used to reduce the level of cholesterol in the blood. They include atorvastatin, fluvastatin, pravastatin, rosuvastatin and simvastatin. They each have different brand names. Who should take a statin? Your doctor will advise if you should take a statin. A statin is usually advised if: daniel mokry covington laWebAllocation of statin therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in borderline- and intermediate-risk patients has traditionally been based on population-based global risk assessment and other clinical and laboratory characteristics. Patient-specific treatment decisions are needed to provide maximal … daniel mitchell cumberland ohioWebObjective: Statin choice, an encounter decision aid (DA), was developed in the USA to facilitate shared decision making between patients and clinicians about the use of statins to reduce cardiovascular risk. We aimed to assess the efficacy of this DA, compared to usual primary care, in Spanish patients with type 2 diabetes. daniel monaghan shoosmiths